These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 22927033

  • 1. Circulating microRNAs in plasma as early detection markers for breast cancer.
    Cuk K, Zucknick M, Heil J, Madhavan D, Schott S, Turchinovich A, Arlt D, Rath M, Sohn C, Benner A, Junkermann H, Schneeweiss A, Burwinkel B.
    Int J Cancer; 2013 Apr 01; 132(7):1602-12. PubMed ID: 22927033
    [Abstract] [Full Text] [Related]

  • 2. Circulating microRNA-based screening tool for breast cancer.
    Frères P, Wenric S, Boukerroucha M, Fasquelle C, Thiry J, Bovy N, Struman I, Geurts P, Collignon J, Schroeder H, Kridelka F, Lifrange E, Jossa V, Bours V, Josse C, Jerusalem G.
    Oncotarget; 2016 Feb 02; 7(5):5416-28. PubMed ID: 26734993
    [Abstract] [Full Text] [Related]

  • 3. Plasma microRNA panel for minimally invasive detection of breast cancer.
    Cuk K, Zucknick M, Madhavan D, Schott S, Golatta M, Heil J, Marmé F, Turchinovich A, Sinn P, Sohn C, Junkermann H, Schneeweiss A, Burwinkel B.
    PLoS One; 2013 Feb 02; 8(10):e76729. PubMed ID: 24194846
    [Abstract] [Full Text] [Related]

  • 4. Plasma microRNAs Predict Chemoresistance in Patients With Metastatic Breast Cancer.
    Shao B, Wang X, Zhang L, Li D, Liu X, Song G, Cao H, Zhu J, Li H.
    Technol Cancer Res Treat; 2019 Jan 01; 18():1533033819828709. PubMed ID: 30786836
    [Abstract] [Full Text] [Related]

  • 5. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
    Kodahl AR, Lyng MB, Binder H, Cold S, Gravgaard K, Knoop AS, Ditzel HJ.
    Mol Oncol; 2014 Jul 01; 8(5):874-83. PubMed ID: 24694649
    [Abstract] [Full Text] [Related]

  • 6. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
    Kassem NM, Makar WS, Kassem HA, Talima S, Tarek M, Hesham H, El-Desouky MA.
    Asian Pac J Cancer Prev; 2019 Sep 01; 20(9):2749-2755. PubMed ID: 31554373
    [Abstract] [Full Text] [Related]

  • 7. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.
    Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A, Bayer CM, Bani MR, Richter S, Adamietz BR, Wenkel E, Rauh C, Beckmann MW, Fasching PA.
    PLoS One; 2012 Sep 01; 7(1):e29770. PubMed ID: 22242178
    [Abstract] [Full Text] [Related]

  • 8. Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.
    Cecene G, Ak S, Eskiler GG, Demirdogen E, Erturk E, Gokgoz S, Polatkan V, Egeli U, Tunca B, Tezcan G, Topal U, Tolunay S, Tasdelen I.
    Asian Pac J Cancer Prev; 2016 Sep 01; 17(9):4241-4246. PubMed ID: 27797225
    [Abstract] [Full Text] [Related]

  • 9. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
    Zhang L, Xu Y, Jin X, Wang Z, Wu Y, Zhao D, Chen G, Li D, Wang X, Cao H, Xie Y, Liang Z.
    Breast Cancer Res Treat; 2015 Nov 01; 154(2):423-34. PubMed ID: 26476723
    [Abstract] [Full Text] [Related]

  • 10. Plasma Circulating Cell-free Nuclear and Mitochondrial DNA as Potential Biomarkers in the Peripheral Blood of Breast Cancer Patients.
    Mahmoud EH, Fawzy A, Ahmad OK, Ali AM.
    Asian Pac J Cancer Prev; 2015 Nov 01; 16(18):8299-305. PubMed ID: 26745076
    [Abstract] [Full Text] [Related]

  • 11. Plasma DNA integrity index as a potential molecular diagnostic marker for breast cancer.
    Kamel AM, Teama S, Fawzy A, El Deftar M.
    Tumour Biol; 2016 Jun 01; 37(6):7565-72. PubMed ID: 26684805
    [Abstract] [Full Text] [Related]

  • 12. Potential diagnostic role of circulating MiRNAs in breast cancer: Implications on clinicopathological characters.
    Swellam M, El Magdoub HM, Hassan NM, Hefny MM, Sobeih ME.
    Clin Biochem; 2018 Jun 01; 56():47-54. PubMed ID: 29679553
    [Abstract] [Full Text] [Related]

  • 13. Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer.
    Guo J, Liu C, Wang W, Liu Y, He H, Chen C, Xiang R, Luo Y.
    PLoS One; 2018 Jun 01; 13(7):e0200716. PubMed ID: 30048472
    [Abstract] [Full Text] [Related]

  • 14. Plasma miR-324-3p and miR-1285 as diagnostic and prognostic biomarkers for early stage lung squamous cell carcinoma.
    Gao X, Wang Y, Zhao H, Wei F, Zhang X, Su Y, Wang C, Li H, Ren X.
    Oncotarget; 2016 Sep 13; 7(37):59664-59675. PubMed ID: 27517633
    [Abstract] [Full Text] [Related]

  • 15. Plasma Circulating Mirnas Profiling for Identification of Potential Breast Cancer Early Detection Biomarkers.
    Jusoh AR, Mohan SV, Lu Ping T, Tengku Din TADAAB, Haron J, Romli RC, Jaafar H, Nafi SN, Tuan Salwani TI, Yahya MM.
    Asian Pac J Cancer Prev; 2021 May 01; 22(5):1375-1381. PubMed ID: 34048164
    [Abstract] [Full Text] [Related]

  • 16. Plasma miR-1273g-3p acts as a potential biomarker for early Breast Ductal Cancer diagnosis.
    Guo H, Zeng X, Li H, Guo Y, Wang T, Guo H, Zhu G, Wang L, Zhou H, Liu K, Chen X, Wang H, Zhao X, Su H, Li Y.
    An Acad Bras Cienc; 2020 May 01; 92(1):e20181203. PubMed ID: 32321013
    [Abstract] [Full Text] [Related]

  • 17. Circulating microRNAs as specific biomarkers for breast cancer detection.
    Ng EK, Li R, Shin VY, Jin HC, Leung CP, Ma ES, Pang R, Chua D, Chu KM, Law WL, Law SY, Poon RT, Kwong A.
    PLoS One; 2013 May 01; 8(1):e53141. PubMed ID: 23301032
    [Abstract] [Full Text] [Related]

  • 18. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
    McAnena P, Tanriverdi K, Curran C, Gilligan K, Freedman JE, Brown JAL, Kerin MJ.
    BMC Cancer; 2019 May 10; 19(1):436. PubMed ID: 31077182
    [Abstract] [Full Text] [Related]

  • 19. Circulating miRNAs revealed as surrogate molecular signatures for the early detection of breast cancer.
    Mishra S, Srivastava AK, Suman S, Kumar V, Shukla Y.
    Cancer Lett; 2015 Dec 01; 369(1):67-75. PubMed ID: 26276721
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers.
    Zearo S, Kim E, Zhu Y, Zhao JT, Sidhu SB, Robinson BG, Soon PSh.
    BMC Cancer; 2014 Mar 18; 14():200. PubMed ID: 24641801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.